Back to the main directory
EarningsReview / Equity
- Europris (Buy, TP: NOK65.00) - Home run by DnB Markets
- Helgeland Sparebank (Buy, TP: NOK102.00) - Solid capital generation by DnB Markets
- B2Holding (Buy, TP: NOK9.50) - Unsecured holding up well by DnB Markets
- Kinnevik (Buy, TP: SEK480.00) - Not the end of tailwind trends by DnB Markets
- Nordea (Buy, TP: SEK96.00) - Continued progress by DnB Markets
- Nobia (Buy, TP: SEK79.00) - Higher estimates at a lower price by DnB Markets
- ABB (Buy, TP: SEK280.00) - Comfort zone by DnB Markets
- Valmet (Hold, TP: EUR28.00) - Strong Q4, solid 2021e in sight by DnB Markets
- Fabege (Hold, TP: SEK135.00) - Key KPI’s in a negative trend by DnB Markets
- Unilever (ULVR LN) by HSBC
- Addtech - Buy/SEK 141 (Hold): Green is good by Nordea
- The Div-il is in the Detail by BNP Paribas Exane
- Axfood - Sell/SEK 150: Decent Q4 but the outlook is less bright from here by Nordea
- Kinnevik - Hold: Strong Q4 but the share remains fairly valued by Nordea
- Nobia - Buy/SEK 83 (78): A vaccine to cure investors' headaches by Nordea
- Stay on target by BNP Paribas Exane
- Fabege - Buy/SEK 149: Letting headwinds to reverse in Q1 2021E by Nordea
- Outokumpu - Buy/EUR 4.50 (Hold): Momentum building up by Nordea
- Taxonomy Make or Break by BNP Paribas Exane
- Danske Bank - Buy/DKK 130 (Hold): Keep your eyes on the ball; we upgrade to Buy by Nordea
- And so to the strategy day ... by BNP Paribas Exane
- S-GandA-X by BNP Paribas Exane
- Nokia - Buy/EUR 4.50: Underlying Q4 beat, outlook in line with consensus by Nordea
- 3Q21 results and 10 questions for management by BNP Paribas Exane
- BioGaia - FY 2021E getting back to organic growth by Danske Bank Equity Research
- Danske Bank (Buy, TP: DKK130.00) - A potential turning point by DnB Markets
- Peab (Buy, TP: SEK115.00) - Targets imply potential upside by DnB Markets
- BioArctic (Buy, TP: SEK200.00) - Focus on Clarity AD by DnB Markets
- Lundbeck (Buy, TP: DKK280.00) - Conservative 2021 guidance by DnB Markets
- Handicare (Hold, TP: SEK50.00) - Waiting to be sold by DnB Markets
- Norske Skog (Buy, TP: NOK40.00) - Big picture unchanged by DnB Markets
- Pandora (Sell, TP: DKK500.00) - Cloudy outlook by DnB Markets
- Konecranes (Buy, TP: EUR40.00) - Strong delivery set to continue by DnB Markets
- GlaxoSmithKline (GSK LN) by HSBC
- Nokia - Early signs of improvement by Danske Bank Equity Research
- Aker BP - Hold (Buy/NOK 280): No icing on the cake by Nordea
- 1st Class Plane Tickets, 1st Class Problems by BNP Paribas Exane
- Basware - Buy/EUR 45: Modest growth outlook due to non-cloud weakness by Nordea
- Munters - Hold: More dusk than dawn by Nordea
- Veoneer - Buy/SEK 295 (Hold): Full speed ahead by Nordea
- Not Just Fluff, Substance Too by BNP Paribas Exane
- Nordic Semiconductor - Showing exceptional strength by Danske Bank Equity Research
- Nordea Bank - No Rating: Continued incremental improvement by Nordea
- Focus is on growth by BNP Paribas Exane
- Securitas - Buy/SEK 165: Taking the necessary structural steps for margins by Nordea
- EV adoption starting to accelerate and 10 questions for mgmt by BNP Paribas Exane
- ABB - Hold (Buy/SEK 250): Time for a breather by Nordea
- Sentiment too bearish, risk/reward skewed to upside by BNP Paribas Exane
- Whitbread : Opérations bienvenues sur la dette ; les campagnes de vaccination massives au Royaume-Uni sont une bonne nouvelle à moyen terme by Oddo BHF
- Lundbeck - Buy/DKK 283 (273): Pain relief by Nordea